Neurocrine Biosciences Inc (NBIX)
125.00
+1.71
(+1.39%)
USD |
NASDAQ |
Nov 21, 16:00
126.09
+1.09
(+0.87%)
Pre-Market: 09:12
Neurocrine Biosciences Total Assets (Quarterly): 3.535B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.535B |
| June 30, 2024 | 3.305B |
| March 31, 2024 | 3.472B |
| December 31, 2023 | 3.251B |
| September 30, 2023 | 2.848B |
| June 30, 2023 | 2.613B |
| March 31, 2023 | 2.360B |
| December 31, 2022 | 2.369B |
| September 30, 2022 | 2.143B |
| June 30, 2022 | 2.006B |
| March 31, 2022 | 2.144B |
| December 31, 2021 | 2.072B |
| September 30, 2021 | 2.017B |
| June 30, 2021 | 1.956B |
| March 31, 2021 | 1.846B |
| December 31, 2020 | 1.735B |
| September 30, 2020 | 1.503B |
| June 30, 2020 | 1.516B |
| March 31, 2020 | 1.362B |
| December 31, 2019 | 1.306B |
| September 30, 2019 | 1.180B |
| June 30, 2019 | 1.067B |
| March 31, 2019 | 957.72M |
| December 31, 2018 | 993.15M |
| September 30, 2018 | 933.75M |
| Date | Value |
|---|---|
| June 30, 2018 | 841.32M |
| March 31, 2018 | 806.36M |
| December 31, 2017 | 817.59M |
| September 30, 2017 | 772.50M |
| June 30, 2017 | 754.09M |
| March 31, 2017 | 289.36M |
| December 31, 2016 | 365.09M |
| September 30, 2016 | 399.16M |
| June 30, 2016 | 429.84M |
| March 31, 2016 | 459.33M |
| December 31, 2015 | 474.78M |
| September 30, 2015 | 492.44M |
| June 30, 2015 | 511.20M |
| March 31, 2015 | 527.78M |
| December 31, 2014 | 243.03M |
| September 30, 2014 | 257.75M |
| June 30, 2014 | 269.54M |
| March 31, 2014 | 279.30M |
| December 31, 2013 | 154.68M |
| September 30, 2013 | 165.97M |
| June 30, 2013 | 174.81M |
| March 31, 2013 | 183.92M |
| December 31, 2012 | 195.98M |
| September 30, 2012 | 193.25M |
| June 30, 2012 | 202.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.306B
Minimum
Dec 2019
3.535B
Maximum
Sep 2024
2.268B
Average
2.108B
Median
Total Assets (Quarterly) Benchmarks
| Repligen Corp | 2.831B |
| West Pharmaceutical Services Inc | 3.675B |
| Bruker Corp | 6.113B |
| The Cooper Companies Inc | 12.11B |
| Integra Lifesciences Holdings Corp | 4.066B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 816.10M |
| Shareholders Equity (Quarterly) | 2.719B |
| Current Ratio | 4.367 |
| Net Debt Paydown Yield | 0.29% |